Cerus Corp (CERS)

$1.23 -0.02 (-1.60%)
Market Cap 235.79M
Revenue (ttm) 201.32M
Net Income (ttm) -20.92M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -10.39%
Debt to Equity Ratio 1.51
Volume 686,000
Avg Vol 1,091,638
Day's Range N/A - N/A
Shares Out 191.70M
Stochastic %K 33%
Beta 1.63
Analysts Strong Sell
Price Target $4.67

Company Profile

Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets an...

Industry: Medical Devices
Sector: Healthcare
Phone: 925 288 6000
Address:
1220 Concord Avenue, Suite 600, Concord, United States
Irun3
Irun3 Sep. 14 at 7:51 PM
$CERS
0 · Reply
2019Vtrader2025
2019Vtrader2025 Sep. 14 at 2:17 PM
$CERS $PACB
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 11 at 11:04 AM
$CERS Outstanding article that hits the mark on CERS's current state. So if you want to refresh your CERS insights or learn about CERS from scratch, this is a must read. https://beyondspx.com/quote/CERS/analysis/cerus-intercepting-a-7-billion-opportunity-with-expanding-commercial-reach-nasdaq-cers
0 · Reply
HorizonBull
HorizonBull Sep. 11 at 3:35 AM
$CERS 10k at 1.18
0 · Reply
VolumePrice
VolumePrice Sep. 11 at 1:01 AM
$CERS If you are bearish, just sell and move on, if shorting, double it, lol
0 · Reply
Irun3
Irun3 Sep. 10 at 11:08 PM
$CERS
0 · Reply
SamCoyote
SamCoyote Sep. 10 at 10:25 PM
$CERS In March 2025, multiple Cerus insiders sold substantial shares. On March 17, CEO William Greenman sold 193,913 shares at $1.45 totaling $281K. COO Vivek Jayaraman sold 75,989 shares for $110K. CFO Kevin Green sold 59,887 shares for $87K. CMO Benjamin Richard and CLO Chrystal Jensen each sold 49,024 shares for $71K. Earlier in March, insiders sold shares at prices between $1.45 and $1.58 in multiple transactions totalling hundreds of thousands of dollars
1 · Reply
VolumePrice
VolumePrice Sep. 10 at 9:53 PM
$CERS I see no insider selling in Q2. They used to sell every quarter, even at $1.45. If they hold off on selling and continue buying, like with the latest insider purchase, some retail investors might be encouraged to start buying and push this over $1.50.
1 · Reply
SamCoyote
SamCoyote Sep. 10 at 9:27 PM
$CERS management sold a lot of shares in 2025, dilution is coming, debt is to high, very sad 😔
0 · Reply
Rezkin
Rezkin Sep. 10 at 8:06 PM
$CERS any news out?
0 · Reply
Latest News on CERS
The German National Blood Advisory Committee Issues Formal Recommendation for Improving the Safety of Platelet Transfusions

Aug 25, 2025, 9:00 AM EDT - 20 days ago

The German National Blood Advisory Committee Issues Formal Recommendation for Improving the Safety of Platelet Transfusions

Cerus Corporation to Participate in the Cantor Global Healthcare Conference 2025

Aug 21, 2025, 8:30 AM EDT - 24 days ago

Cerus Corporation to Participate in the Cantor Global Healthcare Conference 2025

Cerus Corporation (CERS) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 9:02 PM EDT - 5 weeks ago

Cerus Corporation (CERS) Q2 2025 Earnings Call Transcript

Cerus Corporation Announces Second Quarter 2025 Financial Results

Aug 5, 2025, 4:01 PM EDT - 5 weeks ago

Cerus Corporation Announces Second Quarter 2025 Financial Results

Cerus Corporation to Release Second Quarter 2025 Financial Results on August 5, 2025

Jul 22, 2025, 4:15 PM EDT - 7 weeks ago

Cerus Corporation to Release Second Quarter 2025 Financial Results on August 5, 2025

Cerus Corporation Announces Additional Department of Defense Award to Advance Care for Major Hemorrhage in Traumatic Injury

Jul 21, 2025, 8:30 AM EDT - 7 weeks ago

Cerus Corporation Announces Additional Department of Defense Award to Advance Care for Major Hemorrhage in Traumatic Injury

Cerus Corporation Provides INTERCEPT Red Blood Cell CE Mark Application Update

Jul 2, 2025, 8:30 AM EDT - 2 months ago

Cerus Corporation Provides INTERCEPT Red Blood Cell CE Mark Application Update

Cerus Corporation Celebrates World Blood Donor Day 2025

Jun 13, 2025, 4:01 PM EDT - 3 months ago

Cerus Corporation Celebrates World Blood Donor Day 2025

Cerus Corporation to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025

Jun 3, 2025, 4:30 PM EDT - 3 months ago

Cerus Corporation to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025

Cerus Corporation Presents Clinical Data for INTERCEPT Blood System at the 35th Regional International Society of Blood Transfusion Congress in Milan

May 29, 2025, 8:30 AM EDT - 3 months ago

Cerus Corporation Presents Clinical Data for INTERCEPT Blood System at the 35th Regional International Society of Blood Transfusion Congress in Milan

Cerus Corporation Announces Multiple In-Country Regulatory Approvals for INT200 – Next-Generation INTERCEPT Illumination Device

May 28, 2025, 8:30 AM EDT - 3 months ago

Cerus Corporation Announces Multiple In-Country Regulatory Approvals for INT200 – Next-Generation INTERCEPT Illumination Device

Cerus Corporation (CERS) Q1 2025 Earnings Call Transcript

May 1, 2025, 8:26 PM EDT - 4 months ago

Cerus Corporation (CERS) Q1 2025 Earnings Call Transcript

Cerus Corporation Announces First Quarter 2025 Financial Results

May 1, 2025, 4:00 PM EDT - 4 months ago

Cerus Corporation Announces First Quarter 2025 Financial Results

Cerus Corporation to Release First Quarter 2025 Financial Results on May 1, 2025

Apr 17, 2025, 8:30 AM EDT - 5 months ago

Cerus Corporation to Release First Quarter 2025 Financial Results on May 1, 2025

Cerus Corporation Announces Receipt of CE Mark for Next-Generation INTERCEPT Illumination Device (INT200)

Mar 5, 2025, 1:00 PM EST - 6 months ago

Cerus Corporation Announces Receipt of CE Mark for Next-Generation INTERCEPT Illumination Device (INT200)

Cerus Corporation (CERS) Q4 2024 Earnings Call Transcript

Feb 20, 2025, 9:50 PM EST - 7 months ago

Cerus Corporation (CERS) Q4 2024 Earnings Call Transcript

Cerus Corporation Announces Full-Year and Fourth Quarter 2024 Financial Results

Feb 20, 2025, 4:00 PM EST - 7 months ago

Cerus Corporation Announces Full-Year and Fourth Quarter 2024 Financial Results

Cerus Corporation to Participate in the TD Cowen 45th Annual Health Care Conference

Feb 19, 2025, 4:00 PM EST - 7 months ago

Cerus Corporation to Participate in the TD Cowen 45th Annual Health Care Conference

Cerus Corporation to Release Fourth Quarter and Full-Year 2024 Financial Results on February 20, 2025

Feb 7, 2025, 8:30 AM EST - 7 months ago

Cerus Corporation to Release Fourth Quarter and Full-Year 2024 Financial Results on February 20, 2025

Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2024 Product Revenue and Provides Business Update

Jan 13, 2025, 8:30 AM EST - 8 months ago

Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2024 Product Revenue and Provides Business Update

Cerus Corporation to Participate in Upcoming Investor Conferences

Nov 13, 2024, 8:30 AM EST - 10 months ago

Cerus Corporation to Participate in Upcoming Investor Conferences

Cerus Corporation (CERS) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 11:52 PM EDT - 11 months ago

Cerus Corporation (CERS) Q3 2024 Earnings Call Transcript

Cerus Corporation Announces Third Quarter 2024 Financial Results

Oct 30, 2024, 4:00 PM EDT - 11 months ago

Cerus Corporation Announces Third Quarter 2024 Financial Results

Cerus Corporation to Release Third Quarter 2024 Financial Results on October 30, 2024

Oct 18, 2024, 8:30 AM EDT - 11 months ago

Cerus Corporation to Release Third Quarter 2024 Financial Results on October 30, 2024

Cerus Corporation Announces Workshop and Abstracts at the 2024 AABB Annual Meeting

Oct 18, 2024, 8:30 AM EDT - 11 months ago

Cerus Corporation Announces Workshop and Abstracts at the 2024 AABB Annual Meeting

Cerus Corporation Provides Updates on INTERCEPT Red Blood Cell Programs in the U.S. and Europe

Oct 16, 2024, 4:00 PM EDT - 11 months ago

Cerus Corporation Provides Updates on INTERCEPT Red Blood Cell Programs in the U.S. and Europe

Cerus Corporation (CERS) Q2 2024 Earnings Call Transcript

Aug 1, 2024, 8:29 PM EDT - 1 year ago

Cerus Corporation (CERS) Q2 2024 Earnings Call Transcript

Cerus Corporation Announces Second Quarter 2024 Financial Results and Increases Full-Year 2024 Product Revenue Guidance Range

Aug 1, 2024, 4:00 PM EDT - 1 year ago

Cerus Corporation Announces Second Quarter 2024 Financial Results and Increases Full-Year 2024 Product Revenue Guidance Range

Cerus Corporation to Release Second Quarter 2024 Financial Results on August 1, 2024

Jul 18, 2024, 8:30 AM EDT - 1 year ago

Cerus Corporation to Release Second Quarter 2024 Financial Results on August 1, 2024

Cerus Corporation Announces Appointment of Dean Gregory to Board of Directors

Jul 2, 2024, 4:00 PM EDT - 1 year ago

Cerus Corporation Announces Appointment of Dean Gregory to Board of Directors

Cerus Corporation Announces Symposium and Abstracts at the 38th International Congress of the International Society of Blood Transfusion

Jun 21, 2024, 8:30 AM EDT - 1 year ago

Cerus Corporation Announces Symposium and Abstracts at the 38th International Congress of the International Society of Blood Transfusion

Cerus Corporation Celebrates World Blood Donor Day 2024

Jun 14, 2024, 8:30 AM EDT - 1 year ago

Cerus Corporation Celebrates World Blood Donor Day 2024

Cerus Corporation to Participate in 21st Annual Craig-Hallum Institutional Investor Conference

May 22, 2024, 8:30 AM EDT - 1 year ago

Cerus Corporation to Participate in 21st Annual Craig-Hallum Institutional Investor Conference

Cerus Corporation (CERS) Q1 2024 Earnings Call Transcript

May 2, 2024, 7:37 PM EDT - 1 year ago

Cerus Corporation (CERS) Q1 2024 Earnings Call Transcript

Cerus Corporation Announces First Quarter 2024 Financial Results

May 2, 2024, 4:00 PM EDT - 1 year ago

Cerus Corporation Announces First Quarter 2024 Financial Results

Cerus Corporation to Release First Quarter 2024 Financial Results on May 2, 2024

Apr 18, 2024, 8:30 AM EDT - 1 year ago

Cerus Corporation to Release First Quarter 2024 Financial Results on May 2, 2024

Cerus Corporation Announces FDA Approval of Extended Shelf Life for INTERCEPT Platelet Processing Sets – Doubling Previous Shelf Life

Mar 26, 2024, 8:30 AM EDT - 1 year ago

Cerus Corporation Announces FDA Approval of Extended Shelf Life for INTERCEPT Platelet Processing Sets – Doubling Previous Shelf Life

Cerus Corporation Announces Positive Topline Results for the Phase 3 Clinical Trial of the INTERCEPT Blood System for Red Blood Cells in Cardiovascular Surgery Patients

Mar 19, 2024, 8:00 AM EDT - 1 year ago

Cerus Corporation Announces Positive Topline Results for the Phase 3 Clinical Trial of the INTERCEPT Blood System for Red Blood Cells in Cardiovascular Surgery Patients

Cerus Corporation (CERS) Q4 2023 Earnings Call Transcript

Mar 5, 2024, 6:43 PM EST - 1 year ago

Cerus Corporation (CERS) Q4 2023 Earnings Call Transcript

Cerus Corporation Announces Fourth Quarter and Full-Year 2023 Financial Results

Mar 5, 2024, 4:00 PM EST - 1 year ago

Cerus Corporation Announces Fourth Quarter and Full-Year 2023 Financial Results

Cerus Corporation to Release Fourth Quarter and Full-Year 2023 Financial Results on March 5, 2024

Feb 20, 2024, 8:30 AM EST - 1 year ago

Cerus Corporation to Release Fourth Quarter and Full-Year 2023 Financial Results on March 5, 2024

Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2023 Product Revenue and Provides Business Update

Jan 8, 2024, 8:30 AM EST - 1 year ago

Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2023 Product Revenue and Provides Business Update

Cerus Corporation (CERS) Q3 2023 Earnings Call Transcript

Nov 2, 2023, 10:52 PM EDT - 2 years ago

Cerus Corporation (CERS) Q3 2023 Earnings Call Transcript

Cerus Corporation Announces Third Quarter 2023 Financial Results

Nov 2, 2023, 4:00 PM EDT - 2 years ago

Cerus Corporation Announces Third Quarter 2023 Financial Results

Bloodbuy Announces Agreement with Cerus Corporation to Offer Pathogen Reduced Cryoprecipitated Fibrinogen Complex on its Digital Marketplace

Nov 1, 2023, 2:46 PM EDT - 2 years ago

Bloodbuy Announces Agreement with Cerus Corporation to Offer Pathogen Reduced Cryoprecipitated Fibrinogen Complex on its Digital Marketplace

Cerus Corporation to Release Third Quarter 2023 Financial Results on November 2, 2023

Oct 19, 2023, 8:30 AM EDT - 2 years ago

Cerus Corporation to Release Third Quarter 2023 Financial Results on November 2, 2023

Cerus Corporation Announces Workshop and Abstracts at the 2023 AABB Annual Meeting

Oct 10, 2023, 8:30 AM EDT - 2 years ago

Cerus Corporation Announces Workshop and Abstracts at the 2023 AABB Annual Meeting

Cerus Corporation Announces the Appointment of Alicia Goodman as New Chief Human Resources Officer

Sep 27, 2023, 8:30 AM EDT - 2 years ago

Cerus Corporation Announces the Appointment of Alicia Goodman as New Chief Human Resources Officer

Cerus Corporation to Participate in the 2023 Cantor Global Healthcare Conference

Sep 12, 2023, 8:30 AM EDT - 2 years ago

Cerus Corporation to Participate in the 2023 Cantor Global Healthcare Conference

Cerus Corporation Announces Second Quarter 2023 Financial Results

Aug 2, 2023, 4:00 PM EDT - 2 years ago

Cerus Corporation Announces Second Quarter 2023 Financial Results

Irun3
Irun3 Sep. 14 at 7:51 PM
$CERS
0 · Reply
2019Vtrader2025
2019Vtrader2025 Sep. 14 at 2:17 PM
$CERS $PACB
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 11 at 11:04 AM
$CERS Outstanding article that hits the mark on CERS's current state. So if you want to refresh your CERS insights or learn about CERS from scratch, this is a must read. https://beyondspx.com/quote/CERS/analysis/cerus-intercepting-a-7-billion-opportunity-with-expanding-commercial-reach-nasdaq-cers
0 · Reply
HorizonBull
HorizonBull Sep. 11 at 3:35 AM
$CERS 10k at 1.18
0 · Reply
VolumePrice
VolumePrice Sep. 11 at 1:01 AM
$CERS If you are bearish, just sell and move on, if shorting, double it, lol
0 · Reply
Irun3
Irun3 Sep. 10 at 11:08 PM
$CERS
0 · Reply
SamCoyote
SamCoyote Sep. 10 at 10:25 PM
$CERS In March 2025, multiple Cerus insiders sold substantial shares. On March 17, CEO William Greenman sold 193,913 shares at $1.45 totaling $281K. COO Vivek Jayaraman sold 75,989 shares for $110K. CFO Kevin Green sold 59,887 shares for $87K. CMO Benjamin Richard and CLO Chrystal Jensen each sold 49,024 shares for $71K. Earlier in March, insiders sold shares at prices between $1.45 and $1.58 in multiple transactions totalling hundreds of thousands of dollars
1 · Reply
VolumePrice
VolumePrice Sep. 10 at 9:53 PM
$CERS I see no insider selling in Q2. They used to sell every quarter, even at $1.45. If they hold off on selling and continue buying, like with the latest insider purchase, some retail investors might be encouraged to start buying and push this over $1.50.
1 · Reply
SamCoyote
SamCoyote Sep. 10 at 9:27 PM
$CERS management sold a lot of shares in 2025, dilution is coming, debt is to high, very sad 😔
0 · Reply
Rezkin
Rezkin Sep. 10 at 8:06 PM
$CERS any news out?
0 · Reply
Xanatos10
Xanatos10 Sep. 4 at 5:10 PM
$CERS and? Is this thing going up today? It should actually slowly go up.
0 · Reply
Irun3
Irun3 Sep. 3 at 10:27 PM
$CERS
1 · Reply
Me0wth
Me0wth Sep. 3 at 8:44 PM
$AKBA $BCRX $CERS $CHRS $ESPR 1 year bio tech challenge. 5 bio techs, 1000 dollars in each. No adding, no selling for 1 year. Started on November 29, 2024 Back in the green, but barely
6 · Reply
BeefStewart
BeefStewart Aug. 28 at 2:19 PM
$CERS Sometimes when people love a stock very much, but decide that they need to go in a different direction, it may feel bad and lonely, and you may even blame yourself. But just know that it absolutely isn't your fault, and even though I may be invested in $MXCT right now, both $CERS and I still love you very much @N8LongShort 🥹🤗🥰 Sh sh sh 🤗
1 · Reply
BeefStewart
BeefStewart Aug. 28 at 2:06 PM
$CERS I am still here! Just in $MXCT for now and watching CERS for potential reentry 🥹🥰
0 · Reply
N8LongShort
N8LongShort Aug. 28 at 1:43 PM
$CERS sad that beefy gave up
0 · Reply
SamCoyote
SamCoyote Aug. 28 at 10:18 AM
$CERS ARK ETF Trust-ARK Innovation ETF 11.65M Jul 31, 2025 6.08%
0 · Reply
SamCoyote
SamCoyote Aug. 28 at 10:01 AM
$CERS insider purchase at 1.2$ 😀 25k , Dean A Gregory, Director 🙏👌💪
0 · Reply
Xanatos10
Xanatos10 Aug. 27 at 5:47 PM
$CERS shit. I want see 1,20😡
0 · Reply
Xanatos10
Xanatos10 Aug. 27 at 1:17 PM
$CERS going again to 1,20
0 · Reply
HorizonBull
HorizonBull Aug. 26 at 6:50 PM
$CERS so cheap added 5k at 1.37
0 · Reply
Robol
Robol Aug. 26 at 2:02 PM
$CERS
0 · Reply